The Oncology Institute Inc (TOI) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
The Oncology Institute Inc   (NASDAQ: TOI)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

The Oncology Institute Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, The Oncology Institute Inc 's inventory turnover ratio sequentially decreased to 11.17 in the first quarter 2026, unsurprisingly, as the The Oncology Institute Inc markets continue to deteriorate, and TOI's faces growing challenges to bring down its inventories. The Oncology Institute Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 33 days, from 28 days, in the Dec 31 2025 quarter.

Within Healthcare sector 25 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 216 in the fourth quarter 2025, to 283.

TOI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is The Oncology Institute Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TOI Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 97.35 % 68.09 % 86.84 % 39.43 % 6.53 %
Y / Y Cost of Sales Growth 13.39 % 15.21 % 20.95 % 9.95 % -4.88 %
Inventory Turnover Ratio (TTM) 11.17 12.87 13.93 15.68 16.86
TOI's Total Ranking # 283 # 216 # 187 # 200 # 202
Average inventory processing period 33 28 26 23 22
Seq. Inventory Growth 43.94 % -10.63 % 19.61 % 28.26 % 22.6 %
Seq. Cost of Sales Growth 1.3 % -3.43 % 6.69 % 8.64 % 2.92 %




Inventory Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 7
Healthcare Sector # 26
Overall Market # 283

Inventory Turnover Ratio Statistics
High Average Low
25.95 18.31 11.17
(Dec 31 2022)   (Mar 31 2026)



TOI Company Profile >> Back to TOI Efficiency Comparisons >> Compare TOI Inventory Turnover Ratio to its Competitors

Financial Statements
The Oncology Institute Inc 's Inventories $ 24 Millions Visit TOI's Balance sheet
The Oncology Institute Inc 's Cost of Revenues TTM $ 212 Millions Visit TOI's Income Statement
What are TOI's Sales? Visit TOI's Sales by Segment

Other Inventory Turnover Ratios
The Oncology Institute Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Healthcare Facilities Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TOI's Inventory Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TOI's Competitors
Inventory Turnover Ratio for TOI's Suppliers
Inventory Turnover Ratio for TOI's Customers

You may also want to know
TOI's Sales Growth Rates TOI's Pe Price to earnings ratio TOI's Receivables Turnover Ratio TOI's Stock Quote
TOI's Net Income Growth Rates TOI's Ps Price to Sales ratio TOI's Sales per Employee TOI's Asset Turnover Ratio
TOI's Net Margin TOI's Pb Price to Book ratio TOI's Financial Strength Ratios TOI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Autolus Therapeutics Plc  23.69 $ 102.986  Millions$ 4  Millions
Rosecliff Acquisition Corp I  23.60 $ 12.855  Millions$ 1  Millions
Sbc Medical Group Holdings Incorporated  22.54 $ 47.885  Millions$ 2  Millions
Teladoc Health Inc   20.90 $ 772.290  Millions$ 37  Millions
Agape Atp Corporation  20.80 $ 0.667  Millions$ 0  Millions
Labcorp Holdings Inc   19.53 $ 10,065.900  Millions$ 516  Millions
Edap Tms Sa  19.36 $ 64.760  Millions$ 3  Millions
Aspira Women s Health inc   19.29 $ 5.319  Millions$ 0  Millions
Lucid Diagnostics Inc   18.30 $ 8.295  Millions$ 0  Millions
Adapthealth Corp   17.66 $ 2,686.512  Millions$ 152  Millions
Neuronetics Inc   17.04 $ 78.000  Millions$ 5  Millions
Precipio inc   15.93 $ 14.540  Millions$ 1  Millions
Rockwell Medical inc   15.34 $ 56.000  Millions$ 4  Millions
Star Equity Holdings Inc   14.45 $ 112.008  Millions$ 8  Millions
Aurinia Pharmaceuticals Inc   14.12 $ 30.596  Millions$ 2  Millions
Natera Inc   13.48 $ 869.958  Millions$ 65  Millions
Cryo cell International Inc   13.44 $ 7.049  Millions$ 1  Millions
The Oncology Institute Inc   11.17 $ 211.805  Millions$ 19  Millions
Genedx Holdings Corp   11.09 $ 135.000  Millions$ 12  Millions
Infusystem Holdings Inc  10.96 $ 61.593  Millions$ 6  Millions
Irhythm Holdings Inc   10.94 $ 228.000  Millions$ 21  Millions
Earth Science Tech Inc   10.81 $ 8.224  Millions$ 1  Millions
Option Care Health Inc   10.74 $ 4,579.720  Millions$ 427  Millions
Zevra Therapeutics Inc   10.44 $ 17.034  Millions$ 2  Millions
Alnylam Pharmaceuticals Inc   10.38 $ 814.503  Millions$ 78  Millions
Nutriband Inc   10.06 $ 1.291  Millions$ 0  Millions
Lantheus Holdings Inc   9.75 $ 610.000  Millions$ 63  Millions
Sotera Health Company  9.58 $ 531.000  Millions$ 55  Millions
Warby Parker Inc   9.23 $ 415.000  Millions$ 45  Millions
National Vision Holdings Inc   8.90 $ 833.415  Millions$ 94  Millions

Date modified: 2026-06-22T16:30:43+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.